patent antitrust
Jury Hits Takeda with $885M Verdict in Pay-for-Delay Antitrust Case
Patent settlement unlawfully delayed generic competition for Amitiza. By Joy M. Sidhwa When drug makers pay would‑be generic competitors to stay off the market, businesses and…